These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20364301)

  • 1. Small breast epithelial mucin (SBEM) has the potential to be a marker for predicting hematogenous micrometastasis and response to neoadjuvant chemotherapy in breast cancer.
    Liu ZZ; Xie XD; Qu SX; Zheng ZD; Wang YK
    Clin Exp Metastasis; 2010 Apr; 27(4):251-9. PubMed ID: 20364301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study.
    Valladares-Ayerbes M; Iglesias-Díaz P; Díaz-Prado S; Ayude D; Medina V; Haz M; Reboredo M; Antolín S; Calvo L; Antón-Aparicio LM
    J Cancer Res Clin Oncol; 2009 Sep; 135(9):1185-95. PubMed ID: 19221791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of small breast epithelial mucin mRNA in peripheral blood of breast cancer patients and its clinical significance].
    Yang HW; Cao J; Yang NW; Liu JL; Zhang CM; Chen JS; Hong JS; Jiang Y; Su JJ
    Ai Zheng; 2005 Jul; 24(7):842-5. PubMed ID: 16004812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico and in vitro analysis of small breast epithelial mucin as a marker for bone marrow micrometastasis in breast cancer.
    Ayerbes MV; Díaz-Prado S; Ayude D; Campelo RG; Iglesias P; Haz M; Medina V; Gallegos I; Quindós M; Aparicio LA
    Adv Exp Med Biol; 2008; 617():331-9. PubMed ID: 18497056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small breast epithelial mucin tumor tissue expression is associated with increased risk of recurrence and death in triple-negative breast cancer patients.
    Liu L; Liu Z; Qu S; Zheng Z; Liu Y; Xie X; Song F
    Diagn Pathol; 2013 May; 8():71. PubMed ID: 23635316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New methods to improve the safety assessment of cryopreserved ovarian tissue for fertility preservation in breast cancer patients.
    Rodríguez-Iglesias B; Novella-Maestre E; Herraiz S; Díaz-García C; Pellicer N; Pellicer A
    Fertil Steril; 2015 Dec; 104(6):1493-502.e1-2. PubMed ID: 26364839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers.
    Skliris GP; Hubé F; Gheorghiu I; Mutawe MM; Penner C; Watson PH; Murphy LC; Leygue E; Myal Y
    Histopathology; 2008 Feb; 52(3):355-69. PubMed ID: 18269587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
    Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
    Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer.
    Kawase M; Toyama T; Takahashi S; Sato S; Yoshimoto N; Endo Y; Asano T; Kobayashi S; Fujii Y; Yamashita H
    Breast Cancer; 2015 May; 22(3):308-16. PubMed ID: 23771556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
    Liu B; Su F; Chen M; Li Y; Qi X; Xiao J; Li X; Liu X; Liang W; Zhang Y; Zhang J
    Hum Pathol; 2017 Jun; 64():44-52. PubMed ID: 28412211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
    Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
    BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium.
    Miksicek RJ; Myal Y; Watson PH; Walker C; Murphy LC; Leygue E
    Cancer Res; 2002 May; 62(10):2736-40. PubMed ID: 12019145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.
    Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a panel of novel genes for differentiating breast cancer from non-breast tissues.
    O'Brien N; O'Donovan N; Foley D; Hill AD; McDermott E; O'Higgins N; Duffy MJ
    Tumour Biol; 2007; 28(6):312-7. PubMed ID: 18253069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-Step Nucleic Acid Amplification Assay for Detection of Axillary Lymph Node Metastases in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Takamoto K; Shimazu K; Naoi Y; Shimomura A; Shimoda M; Kagara N; Kim SJ; Tamaki Y; Noguchi S
    Ann Surg Oncol; 2016 Jan; 23(1):78-86. PubMed ID: 26152274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome.
    Carey LA; Metzger R; Dees EC; Collichio F; Sartor CI; Ollila DW; Klauber-DeMore N; Halle J; Sawyer L; Moore DT; Graham ML
    J Natl Cancer Inst; 2005 Aug; 97(15):1137-42. PubMed ID: 16077072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy.
    Denkert C; Loibl S; Kronenwett R; Budczies J; von Törne C; Nekljudova V; Darb-Esfahani S; Solbach C; Sinn BV; Petry C; Müller BM; Hilfrich J; Altmann G; Staebler A; Roth C; Ataseven B; Kirchner T; Dietel M; Untch M; von Minckwitz G
    Ann Oncol; 2013 Mar; 24(3):632-9. PubMed ID: 23131391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy.
    Jarzab M; Kowal M; Bal W; Oczko-Wojciechowska M; Rembak-Szynkiewicz J; Kowalska M; Stobiecka E; Chmielik E; Tyszkiewicz T; Kaszuba M; Nowicka E; Lange B; Czarniecka A; Krajewska J; Dyla A; Dobrut M; Lange D; Jarzab B; Bobek-Billewicz B; Tarnawski R
    Folia Histochem Cytobiol; 2016; 54(4):202-209. PubMed ID: 28051275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small breast epithelial mucin promotes the invasion and metastasis of breast cancer cells via promoting epithelial‑to‑mesenchymal transition.
    Li QH; Liu ZZ; Ge YΝ; Liu X; Xie XD; Zheng ZD; Ma YH; Liu B
    Oncol Rep; 2020 Aug; 44(2):509-518. PubMed ID: 32627029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy.
    Schneider J; Gonzalez-Roces S; Pollán M; Lucas R; Tejerina A; Martin M; Alba A
    Breast Cancer Res; 2001; 3(3):183-91. PubMed ID: 11305953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.